m<sup>6</sup>Am-seq reveals the dynamic m<sup>6</sup>Am methylation in the human transcriptome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34362929.
- Also identified by DOI 10.1038/s41467-021-25105-5 and PMC identifier 8346571.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
N<sup>6</sup>,2'-O-dimethyladenosine (m<sup>6</sup>Am), a terminal modification adjacent to the mRNA cap, is a newly discovered reversible RNA modification. Yet, a specific and sensitive tool to directly map transcriptome-wide m<sup>6</sup>Am is lacking. Here, we report m<sup>6</sup>Am-seq, based on selective in vitro demethylation and RNA immunoprecipitation. m<sup>6</sup>Am-seq directly distinguishes m<sup>6</sup>Am and 5'-UTR N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) and enables the identification of m<sup>6</sup>Am at single-base resolution and 5'-UTR m<sup>6</sup>A in the human transcriptome. Using m<sup>6</sup>Am-seq, we also find that m<sup>6</sup>Am and 5'-UTR m<sup>6</sup>A respond dynamically to stimuli, and identify key functional methylation sites that may facilitate cellular stress response. Collectively, m<sup>6</sup>Am-seq reveals the high-confidence m<sup>6</sup>Am and 5'-UTR m<sup>6</sup>A methylome and provides a robust tool for functional studies of the two epitranscriptomic marks.
Medical subject headings
- Adenosine
- Transcriptome